| Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression H Asperger, N Stamm, B Gierke, M Pawlak, U Hofmann, UM Zanger, ... Breast Cancer Research 22, 1-16, 2020 | 47 | 2020 |
| Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021)–Part 1 with Recommendations on … MW Beckmann, FA Stübs, MC Koch, P Mallmann, C Dannecker, A Dietl, ... Geburtshilfe und Frauenheilkunde 82 (02), 139-180, 2022 | 17 | 2022 |
| Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021)–Part 2 with Recommendations on Psycho … T Fehm, FA Stübs, MC Koch, P Mallmann, C Dannecker, A Dietl, ... Geburtshilfe und Frauenheilkunde 82 (02), 181-205, 2022 | 16 | 2022 |
| Efficacy of lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells—the DETECT III clinical trial T Fehm, V Mueller, M Banys-Paluchowski, PA Fasching, TWP Friedl, ... Clinical Chemistry 70 (1), 307-318, 2024 | 14 | 2024 |
| Multiparametric circulating tumor cell analysis to select targeted therapies for breast cancer patients A Franken, B Behrens, F Reinhardt, L Yang, M Rivandi, F Marass, ... Cancers 13 (23), 6004, 2021 | 13 | 2021 |
| ViBiBa: Virtual BioBanking for the DETECT multicenter trial program-decentralized storage and processing H Asperger, JP Cieslik, B Alberter, C Köstler, B Polzer, V Müller, K Pantel, ... Translational Oncology 14 (8), 101132, 2021 | 1 | 2021 |
| A proof-of-concept study to analyze the clinical utility of a circulating tumor cell-based mutation analysis A Franken, B Behrens, F Reinhardt, L Yang, M Rivandi, JP Cieslik, ... Senologie-Zeitschrift für Mammadiagnostik und-therapie 17 (02), 34, 2020 | 1 | 2020 |
| A workflow for the enrichment, the identification, and the isolation of non‐apoptotic single circulating tumor cells for RNA sequencing analysis A Abramova, M Rivandi, L Yang, N Stamm, JP Cieslik, E Honisch, ... Cytometry Part A 105 (4), 242-251, 2024 | | 2024 |
| Retrospective impact of COVID-19 pandemic on primary breast cancer care M Pruss, M Neubacher, F Dietzel, N Krawczyk, JP Cieslik, S Mohrmann, ... Breast Care, 1-1, 2024 | | 2024 |
| Diagnostik, Therapie und Nachsorge der Patientin mit Zervixkarzinom T Fehm, FA Stübs, MC Koch, P Mallmann, C Dannecker, A Dietl, ... Geburtshilfe und Frauenheilkunde 82 (2), 181-205, 2022 | | 2022 |
| Diagnostik, Therapie und Nachsorge der Patientin mit Zervixkarzinom Leitlinie der DGGG, DKG und DKH (S3-Level, AWMF-Registernummer 032/033OL, Mai 2021) Teil 1 mit Empfehlungen … MW Beckmann, FA Stübs, MC Koch, P Mallmann, C Dannecker, A Dietl, ... Geburtshilfe und Frauenheilkunde 82 (2), 139-180, 2022 | | 2022 |
| Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression (vol 22, 75, 2020) H Asperger, N Stamm, B Gierke, M Pawlak, U Hofmann, UM Zanger, ... BREAST CANCER RESEARCH 23 (1), 2021 | | 2021 |
| A proof-of-concept study for the clinical utility of a circulating tumor cell-based mutation analysis A Franken, B Behrens, F Reinhardt, L Yang, M Rivandi, JP Cieslik, ... Geburtshilfe und Frauenheilkunde 80 (10), P014, 2020 | | 2020 |
| Abstract P2-04-02: Progesterone receptor membrane component 1-A novel key regulator in lipid homeostasis drives oncogenic signaling resulting in breast cancer progression H Asperger, M Ludescher, N Stamm, JP Cieslik, U Hofmann, U Zanger, ... Cancer Research 80 (4_Supplement), P2-04-02-P2-04-02, 2020 | | 2020 |
| Abstract P6-10-27: The clinical utility of mutations detected on circulating tumor cells: A proof of concept study based on a metastasized breast cancer index patient A Franken, B Behrens, F Reinhardt, L Yang, M Rivandi, JP Cieslik, ... Cancer Research 80 (4_Supplement), P6-10-27-P6-10-27, 2020 | | 2020 |
| Progesterone receptor membrane component 1-A novel key regulator in lipid homeostasis drives oncogenic signaling resulting in breast cancer progression H Asperger, M Ludescher, N Stamm, JP Cieslik, U Hofmann, U Zanger, ... CANCER RESEARCH 80 (4), 2020 | | 2020 |
| The clinical utility of mutations detected on circulating tumor cells: A proof of concept study based on a metastasized breast cancer index patient A Franken, B Behrens, F Reinhardt, L Yang, M Rivandi, JP Cieslik, ... CANCER RESEARCH 80 (4), 2020 | | 2020 |
| Development of a browser-based sample bank for multicenter liquid biopsy trials H Asperger, J Cieslik, J Naskou, F Meier-Stiegen, D Niederacher, ... Senologie-Zeitschrift für Mammadiagnostik und-therapie 16 (02), 16, 2019 | | 2019 |
| Endocrine Resistance in Breast Cancer-Utilizing Liquid Biopsy and Next Generation Sequencing in Decentralized Multicenter Trials JP Cieslik | | |
